← Back to Clinical Trials
Recruiting NCT07140770

NCT07140770 Sleep and Physical Activity in Patient and Caregiver Dyads Following Allogeneic Hematopoietic Cell Transplantation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07140770
Status Recruiting
Phase
Sponsor M.D. Anderson Cancer Center
Condition Physical Activity
Study Type OBSERVATIONAL
Enrollment 66 participants
Start Date 2025-09-02
Primary Completion 2026-04-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
FitbitQuestionnaire

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 66 participants in total. It began in 2025-09-02 with a primary completion date of 2026-04-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To understand the changes in health-related quality of life of patients and caregivers after allogeneic hematopoietic cell transplantation.

Eligibility Criteria

Eligibility Criteria * Participants and caregivers ages 18 years and older. * Participants diagnosed with a hematologic malignancy with a scheduled allogeneic HCT. * Caregivers identified by participant as the primary caregiver. * Participants and caregivers able to read, speak, and consent in English. * Participants and caregivers able to understand and be willing to sign a written informed consent document. * Participants and caregivers must have internet access via smart phone or tablet with the capacity to 1) download the Fitbit app and 2) complete study assessments with study Exclusion Criteria * Participant or caregiver unable to provide consent, such as cognitively impaired individuals * Participant or caregiver with a diagnosis of sleep apnea. * Primary caregiver is a paid professional, such as a live-in Registered Nurse. * Participant has multiple caregivers and is unable to identify one primary caregiver.

Contact & Investigator

Central Contact

Eileen D Hacker, MD

✉ ehacker@mdanderson.org

📞 713-563-4004

Principal Investigator

Eileen D Hacker, MD

PRINCIPAL INVESTIGATOR

M.D. Anderson Cancer Center

Frequently Asked Questions

Who can join the NCT07140770 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Physical Activity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07140770 currently recruiting?

Yes, NCT07140770 is actively recruiting participants. Contact the research team at ehacker@mdanderson.org for enrollment information.

Where is the NCT07140770 trial being conducted?

This trial is being conducted at Houston, United States.

Who is sponsoring the NCT07140770 clinical trial?

NCT07140770 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Eileen D Hacker, MD at M.D. Anderson Cancer Center. The trial plans to enroll 66 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology